Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Viiv Healthcare Company patents

Recent patent applications related to Viiv Healthcare Company. Viiv Healthcare Company is listed as an Agent/Assignee. Note: Viiv Healthcare Company may have other listings under different names/spellings. We're not affiliated with Viiv Healthcare Company, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "V" | Viiv Healthcare Company-related inventors




Date Viiv Healthcare Company patents (updated weekly) - BOOKMARK this page
08/10/17Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
08/10/17Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
08/03/17Antiviral therapy
07/27/17Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
07/20/17Process for preparing (4r,12as)-n-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,- 12a-hexahydro-2h-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide
05/25/17Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
05/04/17Antiviral therapy
03/23/17Antiviral therapy
02/02/17Pharmaceutical compositions
02/02/17Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
11/24/16Antiviral therapy
10/20/16Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
07/21/16Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
07/14/16Antiviral therapy
05/19/16Substituted cyclopenta[4,5]oxazolo[3,2-a]pyrido[1,2-d]pyrazines as hiv integrase inhibitors
03/03/16Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates
11/26/15Chemical compounds
11/19/15Process for preparing (4r,12as)-n-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2h-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide
08/27/15Antiviral therapy
08/20/15Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
08/13/15Hiv integrase inhibitors
07/02/15(3s,11ar)-6-[(phenylmethyl)oxy]-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-dione of the formula p-9 and/or (3s,11ar)-6-[(phenylmethyl)oxy]-8-bromo-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-dione of the formula p-10
02/26/15Process for preparing pyridinone carboxylic acid aldehydes
09/11/14Chemical compounds
09/11/142-oxonaphthyridine-3-carboxamides hiv integrase inhibitors
08/28/14Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates
02/06/14Chemical compounds
01/30/14Chemical compounds
07/04/13Pharmaceutical compositions







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Viiv Healthcare Company in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Viiv Healthcare Company with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';